SKINVIVE by Juvederm

SKINVIVE by Juvéderm is the first FDA-approved hyaluronic acid (HA) microdroplet injectable designed to improve skin smoothness and hydration, primarily in the cheeks, for adults over 21. Unlike traditional dermal fillers that add volume or contour, SKINVIVE acts as a "skin booster," delivering HA microdroplets intradermally to enhance skin quality without altering facial structure. It replenishes natural HA levels, which diminish with age, to hydrate and smooth the skin. It is also under FDA review for potential use in reducing neck lines, potentially expanding its applications.

Benefits:

• Enhanced Hydration: HA attracts and retains moisture (up to 1,000 times its weight), plumping the skin and reducing dryness for a dewy, radiant glow lasting up to 6–9 months.
• Smoother Skin Texture: Reduces fine lines, wrinkles, and minor imperfections (e.g., shallow acne scars) by stimulating collagen production, improving elasticity and firmness.
• Natural-Looking Results: Does not add volume, ensuring a subtle, refreshed appearance without an "overdone" look.
• Minimal Downtime: Quick 15–20 minute procedure with mild redness or swelling resolving within days; patients can resume normal activities immediately.
• Versatility: Suitable for all Fitzpatrick skin types (I–VI) and can be used off-label on areas like the neck, décolleté, or hands; pairs well with treatments like Botox, microneedling, or fillers.
• Comfort: Contains lidocaine to minimize injection discomfort, with topical numbing often applied.
• High Patient Satisfaction: Clinical studies show 83% of patients reported improved glow, hydration, and skin health at 6 months.